Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vsee Health (VSEE) EPS (Weighted Average and Diluted) (2023 - 2025)

Vsee Health (VSEE) has disclosed EPS (Weighted Average and Diluted) for 3 consecutive years, with -$0.02 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EPS (Weighted Average and Diluted) rose 99.44% year-over-year to -$0.02, compared with a TTM value of $0.46 through Sep 2025, up 111.83%, and an annual FY2024 reading of -$5.65, down 1386.84% over the prior year.
  • EPS (Weighted Average and Diluted) was -$0.02 for Q3 2025 at Vsee Health, up from -$0.16 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.88 in Q4 2024 and bottomed at -$3.58 in Q3 2024.
  • Average EPS (Weighted Average and Diluted) over 3 years is -$0.33, with a median of -$0.11 recorded in 2023.
  • Peak annual rise in EPS (Weighted Average and Diluted) hit 540.0% in 2024, while the deepest fall reached 17800.0% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.2 in 2023, then skyrocketed by 540.0% to $0.88 in 2024, then plummeted by 102.27% to -$0.02 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for VSEE at -$0.02 in Q3 2025, -$0.16 in Q2 2025, and -$0.24 in Q1 2025.